Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sirkka Vene

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Parasites & Vectors|March 13, 2014
Prevalence of tick-borne encephalitis virus in Ixodes ricinus ticks in northern Europe with particular reference to Southern SwedenJohn H-O Pettersson, Irina Golovljova, Sirkka Vene, et al.
Emerging Infectious Diseases|April 19, 2003
Dengue fever in travelers to the tropics, 1998 and 1999Heidi Lindbäck, Johan Lindbäck, Anders Tegnell, et al.
The Journal of Infectious Diseases|January 11, 2011
A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infectionElin Kindberg, Sirkka Vene, Aukse Mickiene, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 2, 2018
Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017Bo Albinsson, Sirkka Vene, Lars Rombo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2002
Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosisAukse Mickiene, Alvydas Laiskonis, Göran Günther, et al.
Vaccine|February 1, 2022
Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trialAnu Kantele, Lars Rombo, Sirkka Vene, et al.
Journal of Medical Virology|October 16, 2004
Characterization of tick-borne encephalitis virus from EstoniaIrina Golovljova, Sirkka Vene, Katarina Brus Sjölander, et al.
Vaccine|February 20, 2010
Vaccine failures after active immunisation against tick-borne encephalitisCharlotta Rydgård Andersson, Sirkka Vene, Mona Insulander, et al.
Emerging Infectious Diseases|July 14, 2006
Tickborne encephalitis virus, Norway and DenmarkTone Skarpaas, Irina Golovljova, Sirkka Vene, et al.
Vaccine|January 1, 2016
Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre studyKatarina Brodin Hertzell, Karlis Pauksens, Lars Rombo, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Parasites & Vectors|March 13, 2014
Prevalence of tick-borne encephalitis virus in Ixodes ricinus ticks in northern Europe with particular reference to Southern SwedenJohn H-O Pettersson, Irina Golovljova, Sirkka Vene, et al.
Emerging Infectious Diseases|April 19, 2003
Dengue fever in travelers to the tropics, 1998 and 1999Heidi Lindbäck, Johan Lindbäck, Anders Tegnell, et al.
The Journal of Infectious Diseases|January 11, 2011
A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infectionElin Kindberg, Sirkka Vene, Aukse Mickiene, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 2, 2018
Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017Bo Albinsson, Sirkka Vene, Lars Rombo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2002
Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosisAukse Mickiene, Alvydas Laiskonis, Göran Günther, et al.
Vaccine|February 1, 2022
Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trialAnu Kantele, Lars Rombo, Sirkka Vene, et al.
Journal of Medical Virology|October 16, 2004
Characterization of tick-borne encephalitis virus from EstoniaIrina Golovljova, Sirkka Vene, Katarina Brus Sjölander, et al.
Vaccine|February 20, 2010
Vaccine failures after active immunisation against tick-borne encephalitisCharlotta Rydgård Andersson, Sirkka Vene, Mona Insulander, et al.
Emerging Infectious Diseases|July 14, 2006
Tickborne encephalitis virus, Norway and DenmarkTone Skarpaas, Irina Golovljova, Sirkka Vene, et al.
Vaccine|January 1, 2016
Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre studyKatarina Brodin Hertzell, Karlis Pauksens, Lars Rombo, et al.
Pageof 6